[1] X. D. Guan and J. Xing, “Ubiquitin in Critical Care Medicine,” Zhonghua Yixue Zazhi, Vol. 87, No. 3, 2007, pp. 273-276.
[2] J. Xing, X. D. Guan and B. Ouyang, “Effects of Exogenous Ubiquitin on Lung Injury and Serum Nitrite/Nitrate in Mice at the Early Stage of Sepsis after Cecal Ligation and Perforation,” Chinese Journal of Respiratory and Critical Care Medicine, Vol. 8, No. 5, 2009, pp. 432-435.
[3] S. A. Earle, A. El-Haddad, M. B. Patel, et al., “Prolongation of Skin Graft Survival by Exogenous Ubiquitin,” Transplantation, Vol. 82, No. 11, 2006, pp. 1554-1546.
[4] X. P. Zhang, D. J. Wu and X. G. Jiang, “ICAM-1 and Acute Pancreatitis Complicated by Acute Lung Injury,” Journal of the Pancreas, Vol. 10, No. 1, 2009, pp. 8-14.
[5] R. A. Carter and I. P. Wicks, “Vascular Cell Adhesion Molecule 1(CD106): A Multifaceted Regulator of Joint Inflammation,” Arthritis & Rheumatism, Vol. 44, No. 5, 2001, pp. 985-994. doi:10.1002/1529-0131(200105)44:5<985::AID-ANR176>3.0.CO;2-P
[6] M. C. Subauste, D. C. Choi and D. Proud, “Transient Exposure of Human Bronchial Epithelial Cells to Cytokines Leads to Persistent Increased Expression of ICAM-1,” Inflammation, Vol. 25, No. 6, 2001, pp. 373-380. doi:10.1023/A:1012850630351
[7] C. Madjdpour, B. Oertli, U. Ziegler, et al., “Lipopolysaccharide Induces Functional ICAM-1 Expression in Rat Alveolar Epithelial Cells in Vitro,” American Journal of Physiology—Lung Cellular and Molecular, Vol. 278, No. 3, 2000, pp. L572-L579.
[8] M. Majetschak, S. M. Cohn, J. A. Nelson, et al., “Effects of Exogenous Ubiquitin in Lethal Endotoxemia,” Surgery, Vol. 135, No. 5, 2004, pp. 536-543. doi:10.1016/j.surg.2003.09.006
[9] J. R. Jacobson and J. G. Garcia, “Novel Therapies for Microvascular Permeability in Sepsis,” Current Drug Targets, Vol. 8, No. 4, 2007, pp. 509-514. doi:10.2174/138945007780362719